AGX Form 144: Proposed sale of 2,000 shares; $584,000 value

AGX: A shareholder filed a Form 144 notice to sell 2,000 common shares, reflecting an aggregate market value of $584,000.

Rhea-AI Filing Summary

AGX: A shareholder filed a Form 144 notice to sell 2,000 common shares, reflecting an aggregate market value of $584,000. The filing lists an approximate sale date of 10/17/2025 on the NYSE, with Morgan Stanley Smith Barney LLC as broker. Shares outstanding were 13,811,575.

The seller acquired 2,000 shares on 10/17/2025 via an option exercise under a registered plan paid in cash. Recent activity disclosed includes prior sales over the last three months: 1,000 shares on 09/19/2025 for $264,535.10 and 2,609 shares on 09/17/2025 for $625,325.12.

Insights

Capital markets counsel

Form 144 discloses a proposed insider sale of 2,000 shares.

The notice states an intention to sell 2,000 AGX common shares with an aggregate value of $584,000 on the NYSE around 10/17/2025, using Morgan Stanley Smith Barney LLC. It also documents that these shares were acquired the same day via option exercise under a registered plan for cash.

The filing lists sales during the prior three months—2,609 shares on 09/17/2025 for $625,325.12 and 1,000 shares on 09/19/2025 for $264,535.10—which are relevant for aggregation under Rule 144 limits. Shares outstanding are shown as 13,811,575, providing baseline context.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AGX shares are proposed for sale in this Form 144?

The notice covers a proposed sale of 2,000 common shares.

What is the aggregate market value of the proposed AGX sale?

The filing lists an aggregate market value of $584,000 for the 2,000 shares.

When is the approximate sale date for the AGX shares?

The filing states an approximate sale date of 10/17/2025.

Which broker and exchange are listed for the AGX Form 144 sale?

Broker: Morgan Stanley Smith Barney LLC; Exchange: NYSE.

How were the AGX shares to be sold acquired?

They were acquired on 10/17/2025 via an option exercise under a registered plan, paid in cash.

What AGX sales occurred in the past three months per the filing?

Reported sales: 2,609 shares on 09/17/2025 for $625,325.12 and 1,000 shares on 09/19/2025 for $264,535.10.

How many AGX shares were outstanding as stated in this notice?

Shares outstanding were 13,811,575.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/17/2025 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001627519
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARGAN, INC.
SEC File Number	001-31756
Address of Issuer	4075 Wilson Boulevard Suite 440 Arlington VIRGINIA 22203
Phone	(301) 315-0027
Name of Person for Whose Account the Securities are To Be Sold	PETER W. GETSINGER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	584000.00	13811575	10/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/17/2025	Exercise of options under a registered plan	Issuer			2000	10/17/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PETER W. GETSINGER 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common	09/19/2025	1000	264535.10
PETER W. GETSINGER 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common	09/17/2025	2609	625325.12

144: Remarks and Signature

Remarks
Date of Notice	10/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter Getsinger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)